Selgus ­vaktsiini doosi hind Euroopa riikidele

(FILES) In this file photo taken on August 13, 2020, a lab technician sorts blood samples inside a lab for a Covid-19 vaccine study at the Research Centers of America (RCA) in Hollywood, Florida,. - Pfizer, Moderna, Novavax: executives at several American laboratories developing Covid-19 vaccines have recently pocketed millions of dollars by selling shares in their companies -- raising questions about the propriety of such a move in the midst of a national health crisis. On the very day that pharmaceutical giant Pfizer announced preliminary data showing its vaccine was 90 percent effective against the coronavirus, its chief executive Albert Bourla sold shares worth $5.6 million. (Photo by CHANDAN KHANNA / AFP) Foto: Chandan Khanna/AFP

Euroopa Liit on sõlminud Covid-19 vaktsiini tootjatega ühistarnelepingud, kuid kuni neljapäevani jäi saladuseks, kui palju vaktsiinid maksavad.

Neljapäeval avaldas Belgia eelarveminister Eva De Bleeker Twitteris vaktsiinide hinnatabeli. Väidetavalt olevat säuts ministri kommunikatsioonimeeskonna viga ning see kustutati kiiresti. Paraku jõudis hollandikeelne ajaleht Het Laatste Nieuws teha sellest kuvatõmmise ning pani veebi.